Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7

specific

Stage III includes: (T3, N0, M0); (T1, N1, M0); (T2, N1, M0); (T3, N1, M0). T3: Tumor measuring more than 4 cm in greatest dimension or with fixation of hemilarynx or extension to esophagus. T1: Tumor limited to one subsite of hypopharynx and/or 2 cm or less in greatest dimension. T2: Tumor invades more than one subsite of the hypopharynx or an adjacent site, or measures more than 2 cm but not more than 4 cm in greatest diameter without fixation of hemilarynx. N0: No regional lymph node meta

65

Centers

72

Active Trials

Cancer Funding

Top Centers for Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7(65)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
High-Volume Research Center
70.8
270.8
3
NCI Comprehensive
High-Volume Research Center
70.8
4
NCI Comprehensive
High-Volume Research Center
70.8
5
NCI Comprehensive
High-Volume Research Center
70.8
6
NCI Comprehensive
High-Volume Research Center
70.8
7
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
High-Volume Research Center
70.8
8
NCI Comprehensive
Active Research Program
48.3
9
NCI Comprehensive
Active Research Program
48.3
10
NCI Comprehensive
Active Research Program
48.3
11
NCI Comprehensive
Active Research Program
48.3
12
NCI Comprehensive
Active Research Program
48.3
13
NCI Comprehensive
Active Research Program
48.3
14
NCI Comprehensive
Active Research Program
48.3
15
NCI Comprehensive
Active Research Program
48.3
16
NCI Comprehensive
Active Research Program
48.3
17
NCI Comprehensive
Active Research Program
48.3
18
NCI Comprehensive
Active Research Program
48.3
19
NCI Comprehensive
Active Research Program
48.3
20
NCI Comprehensive
Active Research Program
48.3
21
NCI Comprehensive
Active Research Program
48.3
22
NCI Comprehensive
Active Research Program
48.3
23
NCI Comprehensive
Active Research Program
48.3
24
NCI Comprehensive
Active Research Program
48.3
25
NCI Comprehensive
Active Research Program
48.3
26
NCI Comprehensive
Active Research Program
48.3
27
NCI Comprehensive
Active Research Program
48.3
28
NCI Comprehensive
Active Research Program
48.3
29
NCI Comprehensive
Active Research Program
48.3
30
NCI Comprehensive
Active Research Program
48.3
31
NCI Comprehensive
Active Research Program
48.3
32
NCI Clinical
Active Research Program
48.3
33
NCI Comprehensive
Active Research Program
48.3
34
Active Research Program
48.3
35
Cedars-Sinai CancerLos Angeles, CA
Active Research Program
48.3
36
NCI Comprehensive
Active Research Program
48.3
37
NCI Clinical
Active Research Program
48.3
38
Active Research Program
48.3
39
NCI Comprehensive
Active Research Program
48.3
40
NCI Comprehensive
Active Research Program
48.3
41
NCI Clinical
Active Research Program
48.3
42
NCI Comprehensive
Active Research Program
48.3
43
NCI Comprehensive
Active Research Program
48.3
44
Active Research Program
48.3
45
NCI Clinical
Active Research Program
48.3
46
NCI Comprehensive
Active Research Program
48.3
47
Active Research Program
48.3
48
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
Active Research Program
48.3
49
Active Research Program
48.3
50
NCI Comprehensive
Active Research Program
48.3
5148.3
52
Active Research Program
48.3
53
Active Research Program
48.3
54
Active Research Program
48.3
55
Active Research Program
48.3
56
Active Research Program
48.3
57
Active Research Program
48.3
58
Active Research Program
48.3
59
Active Research Program
48.3
60
Active Research Program
48.3
61
Active Research Program
48.3
62
Active Research Program
48.3
63
Active Research Program
48.3
64
Active Research Program
48.3
65
Active Research Program
48.3

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →